Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
3.
Med Mal Infect ; 49(5): 335-346, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31155367

ABSTRACT

The serodiagnosis of Lyme borreliosis is based on a two-tier strategy: a screening test using an immunoenzymatic technique (ELISA), followed if positive by a confirmatory test with a western blot technique for its better specificity. Lyme serology has poor sensitivity (30-40%) for erythema migrans and should not be performed. The seroconversion occurs after approximately 6 weeks, with IgG detection (sensitivity and specificity both>90%). Serological follow-up is not recommended as therapeutic success is defined by clinical criteria only. For neuroborreliosis, it is recommended to simultaneously perform ELISA tests in samples of blood and cerebrospinal fluid to test for intrathecal synthesis of Lyme antibodies. Given the continuum between early localized and disseminated borreliosis, and the efficacy of doxycycline for the treatment of neuroborreliosis, doxycycline is preferred as the first-line regimen of erythema migrans (duration, 14 days; alternative: amoxicillin) and neuroborreliosis (duration, 14 days if early, 21 days if late; alternative: ceftriaxone). Treatment of articular manifestations of Lyme borreliosis is based on doxycycline, ceftriaxone, or amoxicillin for 28 days. Patients with persistent symptoms after appropriate treatment of Lyme borreliosis should not be prescribed repeated or prolonged antibacterial treatment. Some patients present with persistent and pleomorphic symptoms after documented or suspected Lyme borreliosis. Another condition is eventually diagnosed in 80% of them.


Subject(s)
Clinical Laboratory Techniques , Lyme Disease , Tick-Borne Diseases , Animals , Clinical Laboratory Techniques/methods , Clinical Laboratory Techniques/standards , Diagnosis, Differential , Disease Progression , France , Humans , Lyme Disease/complications , Lyme Disease/diagnosis , Lyme Disease/pathology , Lyme Disease/therapy , Practice Guidelines as Topic , Societies, Scientific/organization & administration , Societies, Scientific/standards , Tick-Borne Diseases/complications , Tick-Borne Diseases/diagnosis , Tick-Borne Diseases/pathology , Tick-Borne Diseases/therapy
4.
J Fr Ophtalmol ; 35(3): 153-6, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22226389

ABSTRACT

PURPOSE: To evaluate the intraoperative contamination of the anterior chamber in eyes undergoing phacoemulsification in a university teaching hospital. DESIGN: Prospective, non-randomized clinical trial. METHODS: This study included 113 eyes of 113 consecutive patients undergoing cataract surgery performed by experienced surgeons and residents. Phacoemulsification was conducted through a scleral tunnel incision or through a corneal incision. The intraocular lens was implanted with an injector. Aqueous fluid was obtained at the end of surgery before viscoelastic removal, with a cannula through the corneal paracentesis. Povidone-iodine 10% solution was used to prepare the eyebrow and eyelids and povidone-iodine 5% to disinfect the ocular surface. All patients were given a single oral dose of 400mg ofloxacin 2h before surgery. No preoperative antibiotics were administered locally. RESULTS: Anterior chamber fluid aspirates were positive for bacteria in two eyes (1.8%). No eye developed endophthalmitis during the follow-up period. DISCUSSION AND CONCLUSION: Low anterior chamber bacterial contamination rates may be achieved under routine phacoemulsification in a teaching hospital practicing careful antisepsis measures.


Subject(s)
Aqueous Humor/microbiology , Eye Infections, Bacterial/epidemiology , Eye Infections, Bacterial/etiology , Hospitals, University/statistics & numerical data , Phacoemulsification/adverse effects , Surgical Wound Infection/epidemiology , Aged , Bacillus/growth & development , Bacillus/isolation & purification , Bacillus/physiology , Cataract Extraction/adverse effects , Cataract Extraction/statistics & numerical data , Colony Count, Microbial , Endophthalmitis/epidemiology , Endophthalmitis/etiology , Female , Hospitals, Teaching/statistics & numerical data , Humans , Lens Implantation, Intraocular/adverse effects , Lens Implantation, Intraocular/methods , Lens Implantation, Intraocular/statistics & numerical data , Male , Phacoemulsification/statistics & numerical data , Staphylococcus epidermidis/growth & development , Staphylococcus epidermidis/isolation & purification , Staphylococcus epidermidis/physiology , Surgical Wound Infection/microbiology
5.
Ann Biol Clin (Paris) ; 66(2): 215-9, 2008.
Article in French | MEDLINE | ID: mdl-18390433

ABSTRACT

We describe in this article a case of septicaemia with Capnocytophaga suptigena in a premature newborn child. The newborn child exhibited fever at birth, a light inflammatory syndrome and a respiratory failure. The germ was initially identified in the blood-culture of the newborn child by conventional techniques, and then confirmed by sequencing of the ARN 16S. After investigation, it was also found in the mother's vaginal sample. Capnocytophaga sputigena carried by the mother is certainly responsible for infection of the newborn child by ascending way. After antibiotherapy, both mother and child did not present aftereffects. This is the 16th case described in the literature; Capnocytophaga sputigena carried in vaginal area is responsible for preterm labor and for septicaemia associated to respiratory failure of the newborn child. It is thus important not to neglect this germ and to estimate its sensibility to antibiotics.


Subject(s)
Capnocytophaga , Gram-Negative Bacterial Infections , Infant, Premature, Diseases , Pregnancy Complications, Infectious , Respiratory Distress Syndrome, Newborn , Adult , Amikacin/administration & dosage , Amikacin/therapeutic use , Amoxicillin/therapeutic use , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/therapeutic use , Drug Therapy, Combination , Female , Gram-Negative Bacterial Infections/drug therapy , Gram-Negative Bacterial Infections/transmission , Humans , Infant, Newborn , Infant, Premature, Diseases/drug therapy , Infectious Disease Transmission, Vertical , Intensive Care Units, Neonatal , Male , Penicillin G/administration & dosage , Penicillin G/therapeutic use , Pregnancy , Pregnancy Complications, Infectious/drug therapy , Pregnancy Complications, Infectious/microbiology , Respiration, Artificial , Respiratory Distress Syndrome, Newborn/therapy , Time Factors , Treatment Outcome , Vagina/microbiology
6.
Arch Pediatr ; 15(1): 41-4, 2008 Jan.
Article in French | MEDLINE | ID: mdl-18155890

ABSTRACT

We report on a 11-year-old boy who had 2 acute hemiparesis episodes over a period of 1 month. He suffered from headache and fatigue since 1 year. He could not remember neither a tick bite nor a local erythematous skin lesion. The diagnosis of neuroborreliosis was based on intrathecal production of specifics antibodies. Furthermore, the CSF/blood glucose ratio was decreased (0.14), which was rarely described. Cranial MRI showed left capsulothalamic inflammation and a vasculitis. The patient was successfully treated by ceftriaxone. Neuroborreliosis should be considered in all children with stroke-like episode, even in the absence of a history of a tick bite.


Subject(s)
Ceftriaxone/therapeutic use , Lyme Neuroborreliosis/diagnosis , Lyme Neuroborreliosis/drug therapy , Paresis/etiology , Acute Disease , Anti-Bacterial Agents/therapeutic use , Child , Humans , Magnetic Resonance Imaging , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...